Inventor
MCCONNELL BRUCE
CH52 patents
⚠️ This page may combine multiple inventors who share the name “MCCONNELL BRUCE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLYCOM AS
44 patentsUS11040049B2Jun 22, 2021
Composition comprising HMSs/HMOs and use thereof
GLYCOM AS9 citations85
US11040050B2Jun 22, 2021
Composition comprising HMSs/HMOs and use thereof
GLYCOM AS8 citations84
US11026959B2Jun 8, 2021
Synthetic composition and method for treating irritable bowel syndrome
GLYCOM AS9 citations84
US10857168B2Dec 8, 2020
Synthetic composition for microbiota modulation
GLYCOM AS5 citations84
US10828313B2Nov 10, 2020
Synthetic composition for treating metabolic disorders
GLYCOM AS5 citations79
US11529365B2Dec 20, 2022
Synthetic composition for microbiota modulation
GLYCOM AS2 citations73
US11278558B2Mar 22, 2022
Synthetic composition for microbiota modulation
GLYCOM AS5 citations73
US11224605B2Jan 18, 2022
Synthetic composition
GLYCOM AS3 citations73
US10987368B2Apr 27, 2021
Synthetic composition for preventing or treating CVD
GLYCOM AS4 citations73
US10881674B2Jan 5, 2021
Synthetic composition for treating metabolic disorders
GLYCOM AS2 citations73
US10835544B2Nov 17, 2020
Synthetic composition for regulating satiety
GLYCOM AS2 citations73
US10780103B2Sep 22, 2020
Synthetic composition and method for modulating emotion and mood disorders
GLYCOM AS4 citations73
US10751354B2Aug 25, 2020
Synthetic composition for microbiota modulation
GLYCOM AS4 citations73
US10471084B2Nov 12, 2019
Composition and method for treating acute respiratory tract infections
GLYCOM AS2 citations73
US11529364B2Dec 20, 2022
Synthetic composition for treating metabolic disorders
GLYCOM AS4 citations71
US10864224B2Dec 15, 2020
Synthetic composition for treating antibiotic associated complications
GLYCOM AS3 citations69
US11432578B2Sep 6, 2022
Mixture of HMOs
GLYCOM AS1 citations66
US11986487B2May 21, 2024
Mixture of HMOS for treating wheat sensitivity
GLYCOM AS0 citations62
US11896605B2Feb 13, 2024
Composition comprising HMSs/HMOs and use thereof
GLYCOM AS0 citations62
US11896604B2Feb 13, 2024
Composition comprising HMSs/HMOs and use thereof
GLYCOM AS0 citations62
US11890293B2Feb 6, 2024
Synthetic composition for treating metabolic disorders
GLYCOM AS0 citations62
US11696921B2Jul 11, 2023
Synthetic composition for microbiota modulation
GLYCOM AS1 citations62
US11684630B2Jun 27, 2023
Synthetic composition and method for modulating brain function and behaviour
GLYCOM AS0 citations62
US11602545B2Mar 14, 2023
Human milk oligosaccharides for treating migraine
GLYCOM AS0 citations62
US11524019B2Dec 13, 2022
Synthetic composition for reducing allergy symptoms
GLYCOM AS0 citations62
US11491171B2Nov 8, 2022
Synthetic composition and method for modulating emotion and mood disorders
GLYCOM AS0 citations62
US11452736B2Sep 27, 2022
Mixture of HMOs for treating wheat sensitivity
GLYCOM AS0 citations62
US11291677B2Apr 5, 2022
Synthetic composition for microbiota modulation
GLYCOM AS1 citations62
US11173171B2Nov 16, 2021
Mixtures of human milk oligosaccharides comprising 3′-O-sialyllactose
GLYCOM AS0 citations62
US10946032B2Mar 16, 2021
Mixtures of HMOs
GLYCOM AS1 citations62
US10835545B2Nov 17, 2020
Synthetic composition and method for modulating brain function and behaviour
GLYCOM AS1 citations62
US10588917B2Mar 17, 2020
Mixtures of human milk oligosaccharides comprising 3 ′-O-sialyllactose
GLYCOM AS1 citations62
US10314852B2Jun 11, 2019
Mixtures of HMOs
GLYCOM AS1 citations62
US11833165B2Dec 5, 2023
Synthetic composition and method for treating irritable bowel syndrome
GLYCOM AS0 citations61
US11304966B2Apr 19, 2022
Composition comprising HMOs for preventing or reducing nociception
GLYCOM AS0 citations60
US11998558B2Jun 4, 2024
Synthetic composition for treating antibiotic associated complications
GLYCOM AS0 citations58
US12063949B2Aug 20, 2024
Mixture of HMOs
GLYCOM AS0 citations56
US11554131B2Jan 17, 2023
Mixture of HMOs for treating autoimmune diseases
GLYCOM AS0 citations56
US12233079B2Feb 25, 2025
Composition and method for treating humans using low-fodmap diets
GLYCOM AS0 citations52
US11541068B2Jan 3, 2023
HMO compositions and methods for reducing autism spectrum disorder symptoms
GLYCOM AS0 citations52
US11541067B2Jan 3, 2023
HMO compositions and methods for reducing detrimental proteolytic metabolites
GLYCOM AS0 citations52
US10695359B2Jun 30, 2020
Ternary mixtures of 6′-SL, LNnT and LST c
GLYCOM AS0 citations52
US11419884B2Aug 23, 2022
Compositions comprising HMOS, their production and use for the prevention and/or treatment of viral and/or bacterial infections
GLYCOM AS0 citations51
US12458052B2Nov 4, 2025
Human milk oligosaccharides for use in enhancing executive function
GLYCOM AS0 citations50
MCCONNELL BRUCE
3 patentsUNIV HAWAII
1 patent(unassigned)
1 patentNESTLE SA
1 patentShowing the top 50 of 52 patents by PatentIndex Score.